Pfizer Expands Clinical Trial Data Access Policy, Launches Data Access Portal

Pfizer Inc. (NYSE: PFE ) today announced an update of its clinical trial data access policy that will simplify and broaden access to information gathered in Pfizer-sponsored clinical trials. The updated policy builds